Tranexamic acid is most commonly used in cosmetic brightening formulas at concentrations between 2% and 5%. The majority of published cosmetic clinical studies on TXA for hyperpigmentation used concentrations in the 2–3% range applied twice daily, and this has become the benchmark that informed cosmetic chemists reference for a consumer-safe, efficacious formulation. Going above 5% does not necessarily improve efficacy and may increase sensitization risk in the thin periorbital skin; most experienced formulators keep eye-area TXA at 2–3%.
Kojic acid is effective at lower concentrations. The industry standard is 0.5–2%, with 1% being the most commonly used concentration in brightening products. For eye-area use specifically, erring toward the lower end of that range — 0.5–1% — is prudent given the sensitivity of periorbital skin and the fact that kojic acid is a known sensitizer at higher concentrations. The EU has proposed restricting kojic acid to 1% in leave-on products, so formulating at or below 1% future-proofs your product for European market entry.
The synergy between TXA and kojic acid is well-recognized among cosmetic chemists: they inhibit melanin synthesis through different mechanisms (TXA disrupts plasmin-mediated arachidonic acid release and UV-induced melanocyte activation; kojic acid chelates copper in tyrosinase and directly inhibits the enzyme), so their combined effect is additive and allows each to be used at a lower individual concentration than would be required if used alone.
pH management is critical for kojic acid stability. Kojic acid is most stable below pH 5.5 and will oxidize and turn yellow-brown above that range, ruining the product aesthetically. A formula containing both TXA and kojic acid should be buffered to pH 4.5–5.5, which also happens to be favorable for skin barrier integrity in periorbital skin.
When reviewing a manufacturer's stock brightening eye serum base, always request the pH specification and active concentration ranges in writing. If a manufacturer cannot provide a validated concentration for their actives or shows you a formula that runs at pH 6+, that is a red flag for kojic acid stability.
Additional actives that pair well and that manufacturers commonly include in brightening eye serum bases include niacinamide (2–5%), alpha arbutin (1–2%), and peptides such as acetyl tetrapeptide-5. These can round out an efficacious, multi-pathway brightening formula without dramatically increasing cost.
AJ Cosmo Labs connects you with cosmetic chemists and contract manufacturers who can walk you through active concentration decisions specific to your target market and claims strategy — download the iOS app to post your brief and specify your preferred active range upfront.
Ingredients in this answer: Tranexamic Acid · Kojic Acid · Niacinamide · Arbutin
Read the full guide on Private Label Tranexamic & Kojic Acid Eye Serum Low MOQ →